Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 20
Exercise Dysfunction and Pulmonary Rehabilitation Strategies in COPD Patients at High-Altitudes: A Review
Received 14 November 2024
Accepted for publication 16 May 2025
Published 5 June 2025 Volume 2025:20 Pages 1807—1817
DOI https://doi.org/10.2147/COPD.S506552
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Jill Ohar
Lin-Xia Fan, Hong-Juan Wang
Department of Respiratory Medicine, Gansu Provincial Hospital, Lanzhou, Gansu, 730000, People’s Republic of China
Correspondence: Hong-Juan Wang, Department of Respiratory Medicine, Gansu Provincial Hospital, Lanzhou, Gansu, 730000, People’s Republic of China, Tel +86 15117046868, Email [email protected]
Abstract: Chronic Obstructive Pulmonary Disease (COPD) presents significant challenges for patients at high-altitudes, where reduced oxygen availability exacerbates exercise dysfunction. This review explores the related factors behind exercise limitations in high-altitude COPD patients, including chronic hypoxia, impaired pulmonary function, cardiovascular responses, muscle dysfunction, and psychological factors. Effective pulmonary rehabilitation (PR) strategies are essential and should encompass individualized assessments, tailored exercise programs, supplemental oxygen therapy, and nutritional and psychological support. This review highlights the need for further research to develop specific PR protocols for high-altitude COPD patients, focusing on long-term outcomes and innovative approaches to improve access to rehabilitation services. By addressing both physiological and psychological aspects, these strategies aim to enhance the quality of life and functional capacity of COPD patients in high-altitude environments.
Keywords: chronic obstructive pulmonary disease, COPD, high-altitude, exercise dysfunction, pulmonary rehabilitation, hypoxia
Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity and mortality globally, characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities. The World Health Organization estimates that COPD will become the third leading cause of death by 2030, affecting millions of individuals worldwide.1 The disease significantly impairs physical functioning, leading to exercise dysfunction, which is a critical determinant of health-related quality of life in COPD patients.2 COPD is primarily caused by exposure to noxious particles or gases, with tobacco smoke being the most common risk factor. However, in high-altitude regions, the pathophysiology of COPD can be further complicated by environmental factors such as hypoxia, which can exacerbate the disease and lead to additional complications, including pulmonary hypertension and right heart failure.3,4
High-altitude environments, typically defined as elevations above 2500 meters (8200 feet), present unique challenges for individuals with pre-existing respiratory conditions such as COPD. The reduced partial pressure of oxygen at high-altitudes can exacerbate hypoxemia, leading to increased respiratory distress and impaired exercise capacity.5 The interaction between high-altitude and COPD is multifaceted. Chronic hypoxia at high-altitudes can lead to various physiological adaptations, including increased red blood cell production and changes in pulmonary vascular resistance. However, these adaptations may not be sufficient to counteract the effects of COPD, leading to further deterioration of pulmonary function and increased morbidity.6 Moreover, the presence of pulmonary hypertension in COPD patients living at high-altitudes poses additional risks, as it can significantly impair exercise capacity and overall quality of life.7 Patients with COPD often experience a pronounced decline in physical performance when exposed to high-altitude conditions, which can further complicate their management.8 Exercise dysfunction in these patients is multifactorial, influenced by both pulmonary and extra-pulmonary factors, including muscle dysfunction, nutritional deficiencies, and psychological comorbidities.9
Pulmonary rehabilitation (PR) has emerged as an essential component of COPD management, particularly for addressing exercise dysfunction. PR programs typically encompass exercise training, education, and behavioral interventions, aiming to enhance physical and psychological well-being.10 However, the implementation of PR in high-altitude settings requires careful consideration of the unique physiological challenges posed by lower oxygen availability.
Despite the growing body of literature on COPD and PR, there remains a paucity of comprehensive reviews specifically addressing exercise dysfunction and rehabilitation strategies in COPD patients at high-altitudes. This review aims to synthesize current evidence on the impact of high-altitude environments on exercise capacity in COPD patients and to evaluate effective pulmonary rehabilitation strategies that can be employed in these settings.
Method
We conducted a comprehensive search on PubMed, Web of Science and China national knowledge infrastructure (CNKI) up to January 2025, for relevant studies. The search utilized a combination of keywords, including “COPD”, “ Exercise capacity”, “Exercise training”, “Pulmonary rehabilitation”, “High-altitude”, “Hypoxia”, “Quality of Life”, among others. Additionally, the reference lists of the retrieved articles were reviewed to assess their relevance to the focus of this review.
Epidemiology of COPD at High-Altitude
Prevalence of COPD at High-Altitude
Brakema et al reported that the incidence of COPD is higher in high-altitude areas and can be attributed to multiple factors, including environmental pollution and lifestyle choices. The study emphasized the need for further investigation into the role of household air pollution, which is prevalent in many high-altitude communities, as a contributing factor to the increased rates of COPD.11 And some scholars have also observed a significant positive and partial correlation between altitude and the mortality rate of chronic lower respiratory diseases.12 However, other study has yielded opposite results, showing a significant inverse correlation between prevalence/severity of COPD and altitude.13 In summary, there are very few studies on the relationship between high-altitude and COPD prevalence, and due to the geographical limitations of these studies, more research is needed to confirm the relationship between the two.
Risk Factors for COPD in High-Altitude Populations
Hypoxia
Chronic exposure to low oxygen levels at high-altitudes can lead to physiological changes that may worsen COPD symptoms. Chronic hypoxia is a common trait among COPD patients living at high-altitudes, potentially leading to increased pulmonary vascular resistance and the development of pulmonary hypertension.14,15
Environmental Pollution
High-altitude regions often experience significant air pollution from various sources, including biomass burning and industrial emissions. This pollution can exacerbate respiratory conditions, including COPD.11
Socioeconomic Factors
Socioeconomic status can influence access to healthcare, education, and resources for managing COPD. Populations in lower socioeconomic brackets may be more susceptible to developing COPD due to limited access to preventive measures and treatment options.12
Genetic Predisposition
Genetic factors may also play a role in the susceptibility of individuals to COPD at high-altitudes. Studies have suggested that certain genetic markers may influence how individuals respond to hypoxic conditions, potentially affecting their risk of developing COPD.16
Unique Characteristics of High-Altitude COPD
COPD in high-altitude populations presents unique clinical characteristics that differentiate it from COPD at lower altitudes. For instance, patients living at high-altitudes may experience more pronounced symptoms due to the combined effects of hypoxia and airflow limitation. In addition, Gonzalez-Garcia et al found that pulmonary hypertension is more prevalent among COPD patients residing at high-altitudes, which can significantly impair exercise capacity and overall quality of life.7 Based on the particularity of the environment, the diagnostic criteria for COPD may need to be adjusted for high-altitude populations. Traditional spirometric measurements may not accurately reflect pulmonary function in these individuals due to the physiological adaptations that occur at high-altitudes.4 Therefore, it is essential to consider altitude-related factors when diagnosing and managing COPD in these populations.
Exercise Dysfunction and Related Factors in Patients with COPD at High-Altitude
Exercise Dysfunction in COPD Patients at High-Altitude
The systemic effects of COPD lead to cardiovascular complications, muscle atrophy, and osteoporosis, which in turn result in lack of exercise and physical disorders. COPD patients from high-altitude showed significantly different in baseline characteristics, laboratory tests and pulmonary function test.17 These differences have a direct impact on the health-related quality of life of patients with this respiratory disease. The hypoxic conditions encountered at elevated altitudes can lead to reduced oxygen saturation, which exacerbates respiratory symptoms such as dyspnea, cough, and sputum production.18 In addition, high-altitude conditions impose additional strain on respiratory mechanics, resulting in a progressive decrease in exercise capacity, increased dyspnea, dynamic hyperinflation, restrictive mechanical constraints, and gas exchange abnormalities during exercise.3 But there are also results indicating that living at higher altitude is associated with reduced functional exercise capacity as defined by 6MWD, but there is no differences in patient-reported outcomes as defined by symptoms or health status.19
Related Factors Leading to Exercise Intolerance in COPD at High-Altitude
Hypoxia and Its Effects on Exercise Capacity
Exercise dysfunction in COPD can be defined as an inability to perform physical activities at levels that are considered normal for healthy individuals of the same age and sex. Exercise dysfunction may be caused by respiratory limitation due to airflow obstruction, peripheral muscle dysfunction, and cardiovascular limitations.20,21 It is often assessed using exercise tests, such as the six-minute walk test (6MWT) or cardiopulmonary exercise testing (CPET), which measure the distance walked, oxygen uptake (VO2), carbon dioxide output (VCO2), maximal minute ventilation (VE) or ventilatory equivalent for CO2 (VE/VCO2), respectively.22,23
One of the primary mechanisms contributing to exercise dysfunction in high-altitude COPD patients is hypoxia, which occurs due to reduced oxygen availability at elevated altitudes.8 At altitudes above 2500 meters, the partial pressure of oxygen decreases, leading to lower arterial oxygen saturation (SaO2) levels. This hypoxic environment can significantly impair exercise performance, as oxygen is essential for aerobic metabolism and energy production during physical activity.24,25 Hypoxia induces a series of physiological responses aimed at compensating for the reduced oxygen availability.26 These responses include increased ventilation, elevated heart rate, and enhanced red blood cell production.27–29 However, in COPD patients, these compensatory mechanisms may be insufficient due to pre-existing pulmonary function impairment.26 High-altitude environments present additional challenges for COPD patients, as the lower partial pressure of oxygen can exacerbate existing exercise limitations. Therefore, COPD patients experience a significant decrease in exercise capacity when exposed to high-altitudes due to hypoxemia and increased work of breathing.7 The combination of hypoxia and pre-existing respiratory dysfunction can lead to a vicious cycle of decreased physical activity, muscle deconditioning, and worsening respiratory symptoms.30
Impaired Pulmonary Function
COPD is characterized by airflow limitation and excessive expansion of alveoli, which can further exacerbate exercise dysfunction in high-altitude environments.31 Besides, the lung tissue of patients with COPD exhibits an inflammatory response, releasing various inflammatory mediators.4,32 This inflammation not only affects the airways but also leads to systemic effects, including muscle wasting and deconditioning.33 These effects lead to the prevalence of skeletal muscle dysfunction in COPD patients and significantly affect their exercise ability.34
Free radicals and other active substances also play important roles in the pathophysiological processes of COPD.35,36 When these substances overwhelm the availability of antioxidants, oxidative stress occurs, causing damage to lung tissue. These mediators can stimulate abnormal proliferation of endothelial cells and smooth muscle cells in the pulmonary artery, leading to thickening of the vascular wall and restricted blood flow, ultimately causing pulmonary hypertension and even right heart failure.35,36 These changes can significantly impair gas exchange efficiency, particularly during physical exertion when the demand for oxygen increases. In high-altitude conditions, the impaired pulmonary function of COPD patients can lead to a greater mismatch between ventilation and perfusion, resulting in hypoxemia. Consequently, the combination of pre-existing lung function impairment and altitude-related hypoxia can severely limit exercise capacity in COPD patients.31 Honge et al highlights that PPARA expression is downregulated in COPD patients at high-altitude, leading to dysregulation of the hypoxia-inducible factor pathway and exacerbated inflammatory responses.36 PPARA signaling could be a promising therapeutic target for improving lung function and exercise tolerance in these individuals. Given the unique challenges faced by COPD patients at high altitudes, further research into PPARA’s mechanisms can provide critical insights for developing optimized pulmonary rehabilitation strategies tailored to this population.
Cardiovascular Responses
The cardiovascular system plays a crucial role in supporting exercise performance by delivering oxygen-rich blood to the working muscles. In COPD patients, particularly those living at high-altitudes, the cardiovascular response to exercise can be compromised.
Chronic hypoxia can lead to pulmonary hypertension, a condition characterized by elevated blood pressure in the pulmonary arteries, which is common among COPD patients residing at high-altitudes.37 Pulmonary hypertension can result in right ventricular dysfunction, further impairing the heart’s ability to pump blood effectively during exercise. This can lead to reduced cardiac output and exercise intolerance.38 Studies have shown that COPD patients with pulmonary hypertension experience greater limitations in exercise capacity compared to those without this condition.7
Additionally, the increased workload on the heart due to hypoxia can lead to arrhythmias and other cardiovascular complications, further exacerbating exercise dysfunction.39
Muscle Deconditioning and Dysfunction
Another significant factor contributing to exercise dysfunction in high-altitude COPD patients is muscle deconditioning. Skeletal muscle can alter its size and metabolic/contractile characteristics to cope with various stimuli, such as mechanical stress, neuronal activity, metabolic and hormonal effects, as well as environmental factors. Prolonged inactivity due to respiratory limitations can lead to muscle atrophy and weakness, particularly in the lower extremities, which are essential for ambulation and physical activity.40 The combination of hypoxia and muscle deconditioning can create a vicious cycle, where reduced exercise capacity leads to further inactivity and muscle deterioration.
A slow-to-fast transition in fiber type is commonly found in lower limb muscles from patients with COPD, and exposure to high-altitude areas may exacerbate this transition. Therefore, high-altitude environment exacerbates exercise intolerance in patients with COPD and significantly affect their overall quality of life.41 However, chronic inactivity and muscle deconditioning could result in the slow-to-fast fiber-type conversion in lower limb muscles during COPD, further exacerbating their intolerance to exercise. Moreover, COPD is associated with systemic inflammation and oxidative stress, which can negatively impact muscle function.42 Elevated levels of inflammatory markers, such as cytokines, have been observed in COPD patients and can contribute to muscle wasting and dysfunction.43 In addition, the presence of comorbidities, such as cardiovascular disease and metabolic syndrome, can further exacerbate muscle dysfunction and limit exercise capacity in this population.44,45
Psychological Factors
Psychological factors, including anxiety and depression, can also play a role in exercise dysfunction among COPD patients.46 High-altitude environment pose risks of hypoxia, which can lead to psychiatric disorders such as anxiety, depression, and psychosis.47 The experience of chronic respiratory symptoms, coupled with the challenges of living at high-altitudes, can lead to increased levels of anxiety and depression, which can further reduce motivation to engage in physical activity.48 These psychological issues can further complicate COPD management, as they may lead to decreased adherence to treatment regimens, reduced motivation to participate in pulmonary rehabilitation, and a general decline in health status. Effective management of COPD in high-altitude settings must address not only the physiological aspects of the disease but also the psychological health of patients to improve overall outcomes.
In summary, exercise dysfunction in COPD is a multifactorial issue that significantly impacts patients’ quality of life and functional status (Figure 1). The challenges posed by high-altitude environments necessitate a deeper understanding of the mechanisms underlying exercise limitations and the development of targeted rehabilitation strategies.
![]() |
Figure 1 The related factors leading to exercise intolerance in COPD at high-altitude. |
Pulmonary Rehabilitation and Its Challenges at High-Altitudes
Goals and Efficacy of Pulmonary Rehabilitation in COPD
The primary goals of PR are to enhance the quality of life, increase exercise capacity, and reduce symptoms of dyspnea and fatigue. This comprehensive program typically includes exercise training, education, and behavioral interventions tailored to the individual needs of patients.10 Numerous studies have demonstrated the positive impact of pulmonary rehabilitation on various health outcomes in COPD patients. Exercise training is a cornerstone of pulmonary rehabilitation, focusing on both aerobic and resistance training to improve physical endurance and muscle strength. Aerobic exercises, such as walking, cycling, and swimming, are essential for enhancing cardiovascular fitness, while resistance training helps to build muscle strength, which is often compromised in COPD patients due to inactivity and muscle wasting.49 Education is another critical component of PR, providing patients with essential information about their condition, self-management strategies, and the importance of adherence to prescribed therapies. This educational aspect empowers patients to take an active role in managing their disease, leading to better health outcomes.50 Psychosocial support is also integral to pulmonary rehabilitation, as COPD can significantly impact mental health. Counseling and support groups help address the emotional challenges faced by patients, fostering a sense of community and shared experience.51 Despite its proven efficacy, the implementation of pulmonary rehabilitation programs can be challenging, particularly in specific populations, such as those living at high-altitudes.
Challenges of Implementing Pulmonary Rehabilitation at High-Altitudes
The reduced oxygen availability at high-altitudes can significantly impact the exercise capacity of COPD patients. Studies have shown that individuals with COPD experience greater exercise-induced desaturation and increased levels of perceived exertion when exercising in hypoxic conditions.7 As a result, patients may struggle to adhere to rehabilitation protocols, leading to suboptimal outcomes. To address these challenges, successful pulmonary rehabilitation at high-altitudes requires specific adaptation strategies.
While pulmonary rehabilitation is a vital component of COPD management, its implementation at high-altitudes necessitates careful consideration of the unique challenges posed by the environment. The reduced oxygen availability can exacerbate symptoms and limit exercise capacity, making it essential to adopt specific adaptation strategies. Gradual acclimatization, supplemental oxygen, and individualized exercise plans are critical for optimizing rehabilitation outcomes in this patient population.
Pulmonary Rehabilitation Strategies for COPD Patients at High-Altitude
The unique characteristics of high-altitude environments present various challenges for pulmonary rehabilitation in COPD patients, making it essential to develop rehabilitation strategies tailored for COPD patients in these areas. First, personalized assessments should be conducted for COPD patients in high-altitude. Then, based on the patients’ specific circumstances, pulmonary rehabilitation strategies should be formulated, including but not limited to aerobic exercise, resistance training, high-intensity interval training, breathing exercises, oxygen therapy, nutritional support, health education, and self-management (Table 1).
![]() |
Table 1 The Proposed Pulmonary Rehabilitation Measures for COPD Patients at High Altitudes |
Individualized Assessment and Goal Setting
Before initiating a pulmonary rehabilitation program, a comprehensive assessment of the patient’s baseline functional capacity, including exercise tolerance and symptom severity, is essential.52 Tools such as the six-minute walk test (6MWT), the Borg Rating of Perceived Exertion (RPE) scale and assessing symptoms using the Modified Medical Research Council (mMRC) dyspnea scale can help determine the patient’s current status and set realistic, achievable goals.53 Individualized goal setting is crucial, as it fosters motivation and adherence to the program.52 Individualized rehabilitation plans should be developed based on these assessments, taking into account the patient’s specific needs, comorbidities, and altitude-related challenges.
Exercise Modalities
Aerobic Training
Aerobic exercises, such as walking, cycling, and swimming, are fundamental components of any exercise program for COPD patients.54 At high-altitudes, training programs should be tailored to accommodate the reduced oxygen availability. Supplemental oxygen (FIO2 28% and 35%) can significantly increases the duration of exercise for COPD patients at high-altitude.55 This article revealed that the administration of oxygen led to a significant improvement in exercise tolerance (ET) by reducing respiratory load, enhancing cardiovascular performance, and optimizing oxygen transport. However, the greater increases in PaO2 and SaO2 achieved with 35% FIO2 did not provide a notable advantage in ET. This observation carries important considerations for the use of oxygen in rehabilitation programs for COPD patients living in high-altitude regions.
At high-altitudes, low to moderate-intensity aerobic training is recommended to minimize the risk of hypoxemia and excessive fatigue.56 Patients should aim for 20–30 minutes of aerobic exercise, 3–5 times per week, gradually increasing duration and intensity as tolerated.2
Resistance Training
Incorporating resistance training into the exercise regimen can help improve muscle strength and endurance, which are often compromised in COPD patients. Resistance exercises should focus on major muscle groups and can be performed using body weight, resistance bands, or weights. Training sessions should be conducted 2–3 times per week, with an emphasis on proper technique and gradual progression.57
Interval Training
High-intensity interval training (HIIT) involves alternating periods of high-intensity exercise with recovery periods and has gained popularity in recent years due to its effectiveness in improving exercise capacity in various populations.58–60 HITT is an effective therapy for improving peak VO2 in patients with coronary artery disease and heart failure, without causing deterioration of cardiovascular disease risk markers, cardiac structure and function, and health-related quality of life.59,61 A comprehensive multicentre randomized controlled trial revealed that HIIT potentially allowed COPD patients to experience multiple extrapulmonary benefits by reducing the ventilatory burden.62 This approach can be particularly beneficial with hypoxemia, as it allows for short bursts of exertion followed by rest, reducing the risk of excessive fatigue.63
Supplemental Oxygen Therapy
For some COPD patients, supplemental oxygen may be necessary during rehabilitation at high-altitudes. Supplemental oxygen may facilitate muscular training adaptations, particularly in limb muscle dysfunction, thereby contributing to the enhanced training responses on maximal aerobic and functional capacity.64 A meta-analysis revealed that for every 1000 meters of altitude gain, partial pressure of arterial oxygen in patients with COPD decreases by 0.84 kPa.65 However, the decision to use supplemental oxygen should be based on individual assessments of oxygen saturation levels during exercise.55
Breathing Techniques
High-altitude exposure reduces inspiratory muscle strength, and exhibits increased dyspnea, dynamic hyperinflation, restrictive mechanical constraints, and gas exchange abnormalities during exercise in COPD patients.8,66 Inspiratory muscle training (IMT) can reduce the decline in resting SpO2 at altitudes of 4880 m or higher.67 The use of IMT alone in COPD patients can improve inspiratory muscle strength, functional capacity, and pulmonary function, without changing dyspnea and quality of life.68 Instructing diverse breathing techniques in different positions is an important session of rehabilitation in asthma patients at high-altitude,69 this measure may also have a positive effect on disease management for COPD patients living in high-altitude areas.
Nutritional Support
Loss of body mass and exercise intolerance are common findings in COPD and are often difficult to reverse despite optimal nutritional intake.70 Hypoxia aggravates fasting-induced muscle wasting.41 So, proper nutrition is essential for maintaining health in COPD patients, especially at high-altitudes, where energy demands may increase. Unfortunately, there are currently no studies demonstrating nutritional support strategies for COPD patients at high altitudes. Nutritional interventions should focus on ensuring adequate caloric intake and addressing deficiencies that could impact muscle function and overall well-being.
Education and Self-Management
Education is a vital component of pulmonary rehabilitation, empowering patients to manage their condition effectively.2 Self-management for asthma patients at high-altitudes can be used to maintain quality of life and asthma control.71 Combined the sessions for training the conditional physical capabilities and the sessions for health education in COPD patients at high altitudes can improve Muscular strength, Physical activity level and Quality of life associated with health72 so COPD patients should be educated about the importance of exercise, the physiological effects of high-altitude, and strategies for self-monitoring during exercise according to pulmonary rehabilitation guidelines.2,73 Providing patients with tools to recognize their limits and adjust their activities accordingly can enhance adherence to the rehabilitation program and improve overall outcomes.74
Conclusion
COPD presents significant challenges for patients living in high-altitude environments due to the unique physiological stressors associated with reduced oxygen availability. This review highlights the exercise dysfunction, related factors and possible pulmonary rehabilitation strategies in patients with COPD at high-altitudes. Effective management strategies, particularly tailored pulmonary rehabilitation programs, are essential for addressing these challenges. Such programs should incorporate specific exercise regimens, nutritional support, and breathing techniques designed for high-altitude conditions. Moving forward, research should focus on developing and validating PR protocols specifically suited for high-altitude COPD patients. Investigating the long-term effects of high-altitude PR on disease progression, exercise capacity, and quality of life is essential for establishing best practices. Additionally, exploring the integration of telemedicine and remote monitoring could enhance access to PR services for patients in remote high-altitude areas, ensuring necessary support for effective disease management.
Acknowledgments
This work was supported by the fund of the Project of Administration of Traditional Chinese Medicine of Gansu Province of China (NO.GZKG-2022-52), Lanzhou Science and Technology Program (NO. 2020-ZD-22).
Disclosure
The authors declare no conflicts of interest in this work.
References
1. Agustí A, Celli BR, Criner GJ. et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Am J Respir Crit Care Med. 2023;207(7):819–837. doi:10.1164/rccm.202301-0106PP
2. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64. doi:10.1164/rccm.201309-1634ST
3. Bloch KE, Sooronbaev TM, Ulrich S, et al. Counseling Patients with Chronic Obstructive Pulmonary Disease Traveling to high-altitude. High Alt Med Biol. 2023;24(3):158–166. doi:10.1089/ham.2023.0053
4. Huang H, Yang LM. Research Progress of Inflammatory Factors in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension at high-altitude. Altern Ther Health Med. 2023;29(8):689–693.
5. Georges T, Le Blanc C, Ferreol S, et al. Effects of Altitude on Chronic Obstructive Pulmonary Disease Patients: risks and Care. Life. 2021;11(8):798. doi:10.3390/life11080798
6. Wang L, Wang F, Tuo Y, et al. Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes. BMC Pulm Med. 2023;23(1):127. doi:10.1186/s12890-023-02405-8
7. Gonzalez-Garcia M, Aguirre-Franco CE, Vargas-Ramirez L, et al. Effect of pulmonary hypertension on exercise capacity and gas exchange in patients with chronic obstructive pulmonary disease living at high-altitude. Chron Respir Dis. 2022;19:14799731221104095. doi:10.1177/14799731221104095
8. Gonzalez-Garcia M, Barrero M, Maldonado D. Exercise Capacity, Ventilatory Response, and Gas Exchange in COPD Patients With Mild to Severe Obstruction Residing at high-altitude. Front Physiol. 2021;12:668144. doi:10.3389/fphys.2021.668144
9. Burtin C, Saey D, Saglam M, et al. Effectiveness of exercise training in patients with COPD: the role of muscle fatigue. Eur Respir J. 2012;40(2):338–344. doi:10.1183/09031936.00111811
10. Puhan MA, Lareau SC. Evidence-based outcomes from pulmonary rehabilitation in the chronic obstructive pulmonary disease patient. Clin Chest Med. 2014;35(2):295–301. doi:10.1016/j.ccm.2014.02.001
11. Brakema EA, Tabyshova A, Kasteleyn MJ, et al. High COPD prevalence at high-altitude: does household air pollution play a role? Eur Respir J. 2019;53(2):1801193. doi:10.1183/13993003.01193-2018
12. Hwang J, Jang M, Kim N, et al. Positive association between moderate altitude and chronic lower respiratory disease mortality in United States counties. PLoS One. 2018;13(7):e0200557. doi:10.1371/journal.pone.0200557
13. Laniado-Laborin RRA, Batiz F, Batiz F, et al. High-altitude and chronic obstructive pulmonary disease prevalence: a casual or causal correlation? Arch Bronconeumol. 2012;48(5):156–160. doi:10.1016/j.arbres.2011.12.004
14. Güvenç TS, Erer HB, Kul S, et al. Right ventricular morphology and function in chronic obstructive pulmonary disease patients living at high-altitude. Heart Lung Circ. 2013;22(1):31–37. doi:10.1016/j.hlc.2012.08.004
15. Dunham-Snary KJ, Wu D, Sykes EA, et al. Hypoxic Pulmonary Vasoconstriction: from Molecular Mechanisms to Medicine. Chest. 2017;151(1):181–192. doi:10.1016/j.chest.2016.09.001
16. Zeng XH, Suonan GL, Huang Q, et al. The research progress of high-altitude environment-associated chronic obstructive pulmonary disease and therapeutic drugs. Sheng Li Xue Bao. 2023;75(5):691–702.
17. Neşe A, Samancıoğlu Bağlama S. The Effect of Progressive Muscle Relaxation and Deep Breathing Exercises on Dyspnea and Fatigue Symptoms of COPD Patients: a Randomized Controlled Study. Holist Nurs Pract. 2022;36(4):E18–E26. doi:10.1097/HNP.0000000000000531
18. Figueiredo RIN, Azambuja AM, Cureau FV, et al. Inspiratory Muscle Training in COPD. Respir Care. 2020;65(8):1189–1201. doi:10.4187/respcare.07098
19. Beijers RJHCG, Steiner MC, Schols AMWJ. The role of diet and nutrition in the management of COPD. Eur Respir Rev. 2023;32(168):230003. doi:10.1183/16000617.0003-2023
20. Kerti M, Balogh Z, Kelemen K, et al. The relationship between exercise capacity and different functional markers in pulmonary rehabilitation for COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:717–724. doi:10.2147/COPD.S153525
21. Fiorentino G, Esquinas AM, Annunziata A. Exercise and Chronic Obstructive Pulmonary Disease (COPD). Adv Exp Med Biol. 2020;1228:355–368.
22. Ferté J-B, Boyer FC, Taiar R, et al. Impact of resistance training on the 6-minute walk test in individuals with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Ann Phys Rehabil Med. 2022;65(3):101582. doi:10.1016/j.rehab.2021.101582
23. Stringer W, Marciniuk D. The Role of Cardiopulmonary Exercise Testing (CPET) in Pulmonary Rehabilitation (PR) of Chronic Obstructive Pulmonary Disease (COPD) Patients. COPD. 2018;15(6):621–631. doi:10.1080/15412555.2018.1550476
24. Luks AM, Swenson ER. Travel to high-altitude with pre-existing lung disease. Eur Respir J. 2007;29(4):770–792. doi:10.1183/09031936.00052606
25. Holthof K, Bridevaux PO, Frésard I. Underlying lung disease and exposure to terrestrial moderate and high-altitude: personalised risk assessment. BMC Pulm Med. 2022;22(1):187. doi:10.1186/s12890-022-01979-z
26. Rocha A, Arbex FF, Sperandio PA, et al. Exercise intolerance in comorbid COPD and heart failure: the role of impaired aerobic function. Eur Respir J. 2019;53(4):1802386. doi:10.1183/13993003.02386-2018
27. González-García M, Téllez LE. Adaptation to Living at High Altitude in Patients with COPD. Comparative Study of Exercise Capacity and Ventilatory Variables between Patients Residing at High and Low Altitudes in the Andes. High Alt Med Biol. 2024;25(4):266–273. doi:10.1089/ham.2023.0111
28. Hermand E, Lhuissier FJ, Pichon A, et al. Exercising in Hypoxia and Other Stimuli: heart Rate Variability and Ventilatory Oscillations. Life. 2021;11(7):625. doi:10.3390/life11070625
29. Stembridge M, Hoiland RL, Williams AM, et al. The influence of hemoconcentration on hypoxic pulmonary vasoconstriction in acute, prolonged, and lifelong hypoxemia. Am J Physiol Heart Circ Physiol. 2021;321(4):H738–H747. doi:10.1152/ajpheart.00357.2021
30. Furian M, Flueck D, Latshang TD, et al. Exercise performance and symptoms in lowlanders with COPD ascending to moderate altitude: randomized trial. Int J Chron Obstruct Pulmon Dis. 2018;13:3529–3538. doi:10.2147/COPD.S173039
31. Suri R, Markovic D, Woo H, et al. The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: an Observational Cohort Study. Am J Respir Crit Care Med. 2024;210(10):1210–1218. doi:10.1164/rccm.202310-1965OC
32. Xiang Y, Luo X. Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: a Review. Int J Chron Obstruct Pulmon Dis. 2024;19:567–578. doi:10.2147/COPD.S447739
33. Russo C, Valle MS, Casabona A, et al. Vitamin D Impacts on Skeletal Muscle Dysfunction in Patients with COPD Promoting Mitochondrial Health. Biomedicines. 2022;10(4):898. doi:10.3390/biomedicines10040898
34. Man WD, Kemp P, Moxham J, et al. Skeletal muscle dysfunction in COPD: clinical and laboratory observations. Clin Sci. 2009;117(7):251–264. doi:10.1042/CS20080659
35. Li H, Pei W, Wang Y, et al. Mechanism of Action of the Plateau-Adapted Gene PPARA in COPD. Front Biosci. 2024;29(2):68. doi:10.31083/j.fbl2902068
36. Domej W, Oetll K, Renner W. Oxidative stress and free radicals in COPD – implications and relevance for treatment. Int J Chron Obstruct Pulmon Dis. 2014;9:1207–1224. doi:10.2147/COPD.S51226
37. Nakamura K, Akagi S, Ejiri K, et al. Pathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and/or Hypoxia. Int J Mol Sci. 2025;26(2):835. doi:10.3390/ijms26020835
38. Taylor BJ, Shapiro BP, Johnson BD. Exercise intolerance in heart failure: the important role of pulmonary hypertension. Exp Physiol. 2020;105(12):1997–2003. doi:10.1113/EP088105
39. Richalet JP, Hermand E, Lhuissier FJ. Cardiovascular physiology and pathophysiology at high-altitude. Nat Rev Cardiol. 2024;21(2):75–88. doi:10.1038/s41569-023-00924-9
40. Xiong T, Bai X, Wei X, et al. Exercise Rehabilitation and Chronic Respiratory Diseases: effects, Mechanisms, and Therapeutic Benefits. Int J Chron Obstruct Pulmon Dis. 2023;18:1251–1266. doi:10.2147/COPD.S408325
41. De Theije CC, Schols AMWJ, Lamers WH, et al. Hypoxia impairs adaptation of skeletal muscle protein turnover- and AMPK signaling during fasting-induced muscle atrophy. PLoS One. 2018;13(9):e0203630. doi:10.1371/journal.pone.0203630
42. Henrot P, Dupin I, Schilfarth P, et al. Main Pathogenic Mechanisms and Recent Advances in COPD Peripheral Skeletal Muscle Wasting. Int J Mol Sci. 2023;24(7):6454. doi:10.3390/ijms24076454
43. Ferrari R, Caram LM, Faganello MM, et al. Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients. Int J Chron Obstruct Pulmon Dis. 2015;10:1553–1558. doi:10.2147/COPD.S85954
44. Alberto Neder J, O’Donnell DE. Heart, lungs, and muscle interplay in worsening activity-related breathlessness in advanced cardiopulmonary disease. Curr Opin Support Palliat Care. 2020;14(3):157–166. doi:10.1097/SPC.0000000000000516
45. Chan SMH, Selemidis S, Bozinovski S, et al. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies. Pharmacol Ther. 2019;198:160–188. doi:10.1016/j.pharmthera.2019.02.013
46. Hanania NA, O’Donnell DE. Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions. Int J Chron Obstruct Pulmon Dis. 2019;14:1127–1138. doi:10.2147/COPD.S188141
47. Liu B, Yuan ML, Yang M, et al. The Effect of High-Altitude Hypoxia on Neuropsychiatric Functions. High Alt Med Biol. 2024;25(1):26–41. doi:10.1089/ham.2022.0136
48. Kubincová A, Takáč P, Kendrová L, et al. The Effect of Pulmonary Rehabilitation in Mountain Environment on Exercise Capacity and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis. Med Sci Monit. 2018;24:6375–6386. doi:10.12659/MSM.909777
49. Zeng Y, Jiang F, Chen Y, et al. Exercise assessments and trainings of pulmonary rehabilitation in COPD: a literature review. Int J Chron Obstruct Pulmon Dis. 2018;26(13):2013–2023. doi:10.2147/COPD.S167098
50. Oancea C, Fira-Mladinescu O, Timar B, et al. Impact of medical education program on COPD patients: a cohort prospective study. Wien Klin Wochenschr. 2015;127(9–10):388–393. doi:10.1007/s00508-015-0712-z
51. Yohannes AM. Psychosocial Support in Pulmonary Rehabilitation. Respir Care. 2024;69(6):664–677. doi:10.4187/respcare.11850
52. Augustin IML, Spruit MA, Franssen FME, et al. Incorporating Comprehensive Assessment Parameters to Better Characterize and Plan Rehabilitation for Persons with Chronic Obstructive Pulmonary Disease. J Am Med Dir Assoc. 2020;21(12):1986–1991. doi:10.1016/j.jamda.2020.05.026
53. COPD Working Group. Pulmonary rehabilitation for patients with chronic pulmonary disease (COPD): an evidence-based analysis. Ont Health Technol Assess Ser. 2012;12(6):1–75.
54. Troosters T, Janssens W, Demeyer H, et al. Pulmonary rehabilitation and physical interventions. Eur Respir Rev. 2023;32(168):220222. doi:10.1183/16000617.0222-2022
55. Maldonado D, González-García M, Barrero M, et al. Exercise endurance in chronic obstructive pulmonary disease patients at an altitude of 2640 meters breathing air and oxygen (FIO2 28% and 35%): a randomized crossover trial. COPD. 2014;11(4):401–406. doi:10.3109/15412555.2013.836480
56. Su R, Han CX, Chen GQ, et al. Low- and moderate- intensity aerobic exercise improves the physiological acclimatization of lowlanders on the Tibetan plateau. Eur J Sport Sci. 2024;24(6):834–845. doi:10.1002/ejsc.12110
57. Nolan CM, Rochester CL. Exercise Training Modalities for People with Chronic Obstructive Pulmonary Disease. COPD. 2019;16(5–6):378–389. doi:10.1080/15412555.2019.1637834
58. Marzolini S, Robertson AD, MacIntosh BJ, et al. Effect of High-Intensity Interval Training and Moderate-Intensity Continuous Training in People With Poststroke Gait Dysfunction: a Randomized Clinical Trial. J Am Heart Assoc. 2023;12(22):e031532. doi:10.1161/JAHA.123.031532
59. Wang C, Xing J, Zhao B, et al. The Effects of High-Intensity Interval Training on Exercise Capacity and Prognosis in Heart Failure and Coronary Artery Disease: a Systematic Review and Meta-Analysis. Cardiovasc Ther. 2022;2022:4273809. doi:10.1155/2022/4273809
60. Gao M, Huang Y, Wang Q, et al. Effects of High-Intensity Interval Training on Pulmonary Function and Exercise Capacity in Individuals with Chronic Obstructive Pulmonary Disease: a Meta-Analysis and Systematic Review. Adv Ther. 2022;39(1):94–116. doi:10.1007/s12325-021-01920-6
61. McGregor G, Powell R, Begg B, et al. High-intensity interval training in cardiac rehabilitation: a multi-centre randomized controlled trial. Eur J Prev Cardiol. 2023;30(9):745–755. doi:10.1093/eurjpc/zwad039
62. Jakobsson J, Burtin C, Hedlund M, et al. Effects and mechanisms of supramaximal high-intensity interval training on extrapulmonary manifestations in people with and without chronic obstructive pulmonary disease (COPD-HIIT): study protocol for a multi-centre, randomized controlled trial. Trials. 2024;25(1):664. doi:10.1186/s13063-024-08481-3
63. Aakerøy L, Nørstebø EA, Thomas KM, et al. High-intensity interval training and pulmonary hemodynamics in COPD with hypoxemia. Eur Clin Respir J. 2021;8(1):1984642. doi:10.1080/20018525.2021.1984642
64. Neunhäuserer D, Hudelmaier M, Niederseer D, et al. The Impact of Exercise Training and Supplemental Oxygen on Peripheral Muscles in Chronic Obstructive Pulmonary Disease: a Randomized Controlled Trial. Med Sci Sports Exerc. 2023;55(12):2123–2131. doi:10.1249/MSS.0000000000003268
65. Sevik A, Gaisl T, Forrer A, et al. High altitudes and partial pressure of arterial oxygen in patients with chronic obstructive pulmonary disease - A systematic review and meta-analysis. Pulmonology. 2025;31(1):2416860. doi:10.1016/j.pulmoe.2024.06.002
66. Fasano V, Paolucci E, Pomidori L, et al. High-altitude exposure reduces inspiratory muscle strength. Int J Sports Med. 2007;28(5):426–430. doi:10.1055/s-2006-924367
67. Lomax M. Inspiratory muscle training, altitude, and arterial oxygen desaturation: a preliminary investigation. Aviat Space Environ Med. 2010;81(5):498–501. doi:10.3357/ASEM.2718.2010
68. Ammous O, Feki W, Lotfi T, et al. Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2023;1(1):CD013778.
69. Saxer S, Schneider SR, Appenzeller P, et al. Asthma rehabilitation at high vs. low altitude: randomized parallel-group trial. BMC Pulm Med. 2019;19(1):134. doi:10.1186/s12890-019-0890-y
70. Keogh E, Mark Williams E. Managing malnutrition in COPD: a review. Respir Med. 2021;176:106248. doi:10.1016/j.rmed.2020.106248
71. Beerthuizen T, Rijssenbeek-Nouwens LH, van Koppen SM, et al. Internet-Based Self-Management Support After High-Altitude Climate Treatment for Severe Asthma: randomized Controlled Trial. J Med Internet Res. 2020;22(7):e13145. doi:10.2196/13145
72. Villamil-Parra W, Cristancho-Mejía É, Ramon Torrella J, et al. Effects of a physical exercise program on HIF-1alpha in people with Chronic Obstructive Pulmonary Disease living at high altitude: study protocol for a clinical trial. Trials. 2023;24(1):698. doi:10.1186/s13063-023-07698-y
73. Alison JA, McKeough ZJ, Johnston K, et al. Australian and New Zealand Pulmonary Rehabilitation Guidelines. Respirology. 2017;22(4):800–819. doi:10.1111/resp.13025
74. Sigurgeirsdottir J, Halldorsdottir S, Arnardottir RH, et al. COPD patients’ experiences, self-reported needs, and needs-driven strategies to cope with self-management. Int J Chron Obstruct Pulmon Dis. 2019;14:1033–1043. doi:10.2147/COPD.S201068
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended articles

A Pharmacodynamic Evaluation of the Protective Effects of Roxadustat Against Hypoxic Injury at High Altitude
Guo Q, Li X, Li W, Wang R, Zhao A, Wang Z
Drug Design, Development and Therapy 2023, 17:75-85
Published Date: 15 January 2023
Exercise Performance of Lowlanders with Chronic Obstructive Pulmonary Disease Acutely Exposed to 2048 m: A Randomized Cross-Over Trial
Bitos K, Kuehne T, Latshang TD, Aeschbacher SS, Huber F, Flueck D, Hasler ED, Scheiwiller PM, Lichtblau M, Ulrich S, Bloch KE, Furian M
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1753-1762
Published Date: 17 August 2023